Major histocompatibility complex (MHC) class I molecules present peptides on the cell surface to CD8 + T cells, which is critical for the killing of virus-infected or transformed cells. Precursors of MHC class I-presented peptides are trimmed to mature epitopes by the aminopeptidase ERAP1. The US2-US11 genomic region of human cytomegalovirus (HCMV) is dispensable for viral replication and encodes three microRNAs (miRNAs). We show here that HCMV miR-US4-1 specifically downregulated ERAP1 expression during viral infection. Accordingly, the trimming of HCMV-derived peptides was inhibited, which led to less susceptibility of infected cells to HCMV-specific cytotoxic T lymphocytes (CTLs). Our findings identify a previously unknown viral miRNA-based CTL-evasion mechanism that targets a key step in the MHC class I antigen-processing pathway.
A r t i c l e s
Major histocompatibility complex (MHC) class I molecules bind peptides and present them on the cell surface for recognition by CD8 + T cells. Cytosolic peptides generated by the proteasomes and prematurely translated peptides are transported to the endoplasmic reticulum by means of the transporter associated with antigen processing complex 1, 2 . Some of these peptides are further processed by aminopeptidases that reside in the endoplasmic reticulum, such as ERAP1 (also called A-LAP, ARTS-1 or PILS-AP), and peptide trimming by ERAP1 in the endoplasmic reticulum is a crucial step for determining the quality and quantity of optimal production of antigenic peptides and the stability of the heterotrimer of MHC class I-β 2 -microglobulinpeptide [3] [4] [5] [6] . ERAP1 trims relatively long peptides efficiently in a sequence-specific manner, which results in the accumulation of optimal peptides eight to nine amino acids in length 5, 7, 8 . ERAP1 therefore acts as a 'molecular ruler' for the production of antigenic peptides 9 . In addition, genome-wide association studies have associated nonsynonymous single-nucleotide polymorphisms in ERAP1 with ankylosing spondylitis 4 . Additionally, ERAP1 has non-peptide-processing functions through its role in the shedding of cytokine receptors 4 .
MicroRNAs (miRNAs) are small RNAs 19-23 nucleotides in length that regulate gene expression by complete or partial base pairing with the 3′ untranslated region (UTR) of their target mRNA, which leads to the cleavage, destabilization or translational repression of mRNA 10 . Since the first report in 2004 that viruses express miRNAs 11 , many viral miRNAs have been discovered, mainly related to viral proliferation and survival-related evasion of the immune response (immunoevasion), although this is based on a limited number of studies 12 . The β-herpesvirus human cytomegalovirus (HCMV) expresses at least 14 miRNAs during productive infection 13, 14 . One HCMV-encoded miRNA, miR-UL112-1, targets three HCMV genes involved in viral replication 15 , and another HCMV-encoded miRNA, miR-US25-1, can downregulate many host genes associated with cellcycle control and tumor progression by interacting with the 5′ UTR of the target mRNA 16 . In addition, miR-UL112-1 targets one cellular gene, encoding MHC class I-related chain B, to enable escape from the natural killer cell-mediated immune response 17 , and miR-UL112-1 can also repress the expression of UL114, a uracil DNA glycosylase that can influence viral replication 18 and whose gene is antisense to miR-UL112-1. However, the cellular or host targets of many viral miRNAs remain to be elucidated.
Many viruses have evolved strategies that target crucial stages of the MHC class I antigen-presentation pathway to prevent viral peptides from being presented to CD8 + T cells 1 . The 9-kilobase US2-US11 region in the HCMV genome encodes at least five glycoproteins (US2, US3, US6, US10 and US11) specifically dedicated to interfering with the presentation of antigenic peptides to CD8 + T cells 1, [19] [20] [21] [22] [23] . Because deletion of the US2-US11 genomic segment has no influence on viral replication 24 , the US2-US11 region is considered a reservoir of viral genes that encode molecules whose functions are to escape the presentation of viral antigens by MHC class I molecules.
In this study, we demonstrate that HCMV miR-US4-1 specifically targeted ERAP1 and thereby inhibited the trimming of precursors to the MHC class I-presented mature epitopes, which resulted in the inhibition of cytotoxic T lymphocyte (CTL) immune responses. Our findings expand understanding of the strategy of the host-virus 'arms race' . They also reinforce the proposal that the US2-US11 region in the HCMV genome has evolved into a reservoir of genes that encode viral immunoevasive molecules that act against the elimination of HCMV-infected cells by CD8 + T cells of the host immune response.
RESULTS

Identification of ERAP1 as a host target of miR-US4-1
We found 3 miRNAs (miR-US4-1, miR-US5-1 and miR-US5-2) among the total 14 HCMV miRNAs encoded by the presumptive US4 and US5 loci in the US2-US11 region 13, 14 (Supplementary Fig. 1a) . Given that many products of this region can block the MHC class I antigenpresentation pathway, we hypothesized that some of these miRNAs might be able to inhibit MHC class I-mediated antigen presentation. To identify potential cellular targets of HCMV miRNAs encoded by the US2-US11 region, we investigated changes in the host-cell transcriptome in response to the expression of HCMV miR-US4-1, miR-US5-1 and miR-US5-2. We synthesized the three miRNAs, as well as small interfering RNA (siRNA) targeting the open reading frame of sequence encoding green fluorescent protein (siGFP) or protein disulfide isomerase as a positive control for evaluating transfection efficiency. We transfected these synthetic RNAs twice into U373MG cells, an HCMV-permissive human astrocytoma cell line 25 , at intervals of 48 h to maximize transfection efficiency. Immunoblot analysis showed that the expression of protein disulfide isomerase was much lower in cells transfected with siRNA specific for this protein (Supplementary Fig. 1b) , which confirmed our expectation that the transfection efficiency was sufficient to proceed to microarray analysis of the three HCMV miRNAs. Among the top-ranked genes with the most diminished expression, ERAP1 mRNA was downregulated more than 90% by miR-US4-1 (Fig. 1a) , whereas miR-US5-1 and miR-US5-2 did not substantially alter the expression of ERAP1 mRNA (Fig. 1b,c) . On the basis of these results and published studies showing that ERAP1 has a critical role in regulating the antigenic peptide pool in the endoplasmic reticulum 4 , we hypothesized that among these three HCMV miRNAs, miR-US4-1 targets ERAP1 to inhibit MHC class I-mediated antigen presentation.
Downregulation of ERAP1 mRNA and protein by miR-US4-1
Human ERAP1 produced at least two mRNA isoforms, isoform a (ERAP1a) and isoform b (ERAP1b; Supplementary Fig. 2a) . Although the amino acid sequences of both isoforms were almost identical, the 3′ UTR sequence of ERAP1a differed from that of ERAP1b. Because the base pairing between an miRNA and its target mRNA generally occurs in the 3′ UTR of the target mRNA in animal cells 26 , we investigated which isoform was targeted by miR-US4-1. To confirm the microarray data, we expressed control miRNA, miR-US4-1 and three siRNAs as positive controls for knockdown of ERAP1: siERAP1, which targets the open reading frames of both isoforms; siERAP1a, which targets the 3′ UTR of ERAP1a; and siERAP1b, which targets the 3′ UTR of ERAP1b. We expressed all three siRNAs as forms of small hairpin RNA (shRNA) in the human embryonic kidney cell line HEK293T. We did quantitative real-time PCR analysis with primers that bind specific regions in the 3′ UTR of each isoform (Supplementary Fig. 2a) . As expected, expression of siERAP1a or siERAP1b resulted in lower expression of ERAP1a or ERAP1b mRNA, respectively, and siERAP1 downregulated both isoforms. ERAP1a mRNA was not downregulated by expression of miR-US4-1 (Fig. 1d) , whereas ERAP1b mRNA was more than 60% lower in abundance after expression of miR-US4-1 (Fig. 1e) . These results indicated that miR-US4-1 specifically downregulated ERAP1b mRNA but not ERAP1a mRNA.
Next we determined whether the downregulation of ERAP1b mRNA led to less ERAP1b protein. As a control, we constructed a miR-US4-1 vector (miR-US4-1(M)) with mutation of the 'seed' nucleotides (nucleotides 2-8 at the 5′ end of the mature miRNA; Supplementary  Fig. 2b ) because the seed sequence of an miRNA is considered a critical determinant of the recognition and base pairing of target mRNA by miRNA, and most miRNAs bind to their target mRNA 3′ UTRs with complete Watson-Crick base pairing in the seed region 27 . We expressed control miRNA (siGFP), miR-US4-1, siERAP1 and miR-US4-1(M) in HeLa human cervical cancer cells. We investigated the expression of 
A r t i c l e s miR-US4-1 by RNase-protection assay (Fig. 1f) or RNA blot analysis (Fig. 1g) . Immunoblot analysis showed that ERAP1 expression was lower after miR-US4-1 expression than after expression of control miRNA, but miR-US4-1(M) did not affect ERAP1 protein expression (Fig. 1f) . The ability of miR-US4-1 to downregulate ERAP1 protein seemed to be as effective as that of siERAP1 (Fig. 1f) . ERAP1b mRNA was 3.8-6.4 times more abundant than ERAP1a mRNA in the cells used in these experiments ( Supplementary Fig. 3a ). To rule out the possibility that direct comparison of ERAP1a and ERAP1b mRNA might have been biased because of differences in primer efficiency, we confirmed that both primers amplified each targeted ERAP1 isoform equally ( Supplementary Fig. 3b,c) . Thus, our findings suggest that the amount ERAP1b protein accounts for most of the ERAP1 content in the cell. In dose-dependent experiments, the amount of ERAP1 protein was inversely proportional to miR-US4-1 expression (Fig. 1f) . These results demonstrated that miR-US4-1 specifically downregulated ERAP1b mRNA, thereby diminishing the overall amount of cellular ERAP1 protein.
Direct targeting of the ERAP1b mRNA 3′ UTR by miR-US4-1
To confirm that the diminished ERAP1b mRNA and ERAP1 protein was due to direct targeting by miR-US4-1 and to identify potential target sites in the 3′ UTR of ERAP1 mRNA, we did bioinformatic scanning of the 3′ UTRs of ERAP1a and ERAP1b with the RNAhybrid algorithm 28 and rna22 algorithm 29 . We selected the most likely target site in the 3′ UTR sequences of ERAP1a mRNA ( Fig. 2a) and ERAP1b mRNA ( Fig. 2b) , focusing on base pairing in the seed sequence of the miRNA and its binding energy, because the seed sequence is considered a critical determinant in the recognition of target mRNA by miRNA 10 .
We mutated two nucleotides in the predicted seed binding sites of the 3′ UTR of each isoform (Fig. 2a,b) , then did a luciferase reporter assay. Notably, we observed that miR-US4-1 significantly downregulated the expression of firefly luciferase fused to the ERAP1b wild-type 3′ UTR, whereas miR-US4-1(M) did not ( Fig. 2c) . In the reciprocal experiment in which we transfected cells with the firefly luciferase vector fused to the mutated ERAP1b 3′ UTR, neither wild-type miR-US4-1 nor miR-US4-1(M) had an effect on the expression of firefly luciferase (Fig. 2c) . The expression of the firefly luciferase vector containing either the wild-type or mutated ERAP1a 3′ UTR was not affected by wild-type miR-US4-1 or miR-US4-1(M) (Fig. 2c) . Given that the minimum free energy for the hybridization of miR-US4-1 to ERAP1b (−30.5 kcal/mol; Fig. 2b ) was greater than that for ERAP1a (−20.4 kcal/mol; Fig. 2a ), the insensitivity of ERAP1a to miR-US4-1 might have been attributable to insufficient base pairing between these. In addition, we examined the dose-dependent effect of miR-US4-1 on luciferase reporters containing the ERAP1 3′ UTR derivatives. After confirming the dose-dependent expression of miR-US4-1 by RNA blot analysis ( Supplementary Fig. 4) , we transfected luciferase reporter 3′ UTR vectors into HEK293T cells with dose-dependent expression of miR-US4-1 and did a luciferase reporter assay. We observed that the expression of firefly luciferase from the vector containing wild-type ERAP1b 3′ UTR was inversely proportional to the expression of miR-US4-1, whereas the expression of firefly luciferase from vector containing wild-type or mutated ERAP1a 3′ UTR or mutated ERAP1b 3′ UTR was not affected by miR-US4-1 (Fig. 2d) . Given these observations, we concluded that miR-US4-1 targeted only the 3′ UTR of ERAP1b mRNA, but not the 3′ UTR of ERAP1a mRNA, in a seed region binding-dependent manner. A Fig. 5a ), we transfected HEK293T cells with vector expressing sh-miR-21 along with vectors for human AGO1, AGO2, AGO3 or AGO4 tagged with Flag at the N terminus to confirm the hypothesis that Flag-tagged human AGO proteins formed a complex with miR-21 expressed from sh-miR-21. Although human miRNAs, including miR-21, were generally able to form a complex with each human AGO protein (AGO1-AGO4) in the RISC ( Supplementary  Fig. 5b ) 33 , we used a combination of four Flag-tagged human AGO proteins to exclude the possibility that a specific miRNA targets the specific mRNA by one or more AGO proteins. At 48 h after transfection, we confirmed the expression of Flag-tagged human AGO proteins in total cell lysates and the enrichment of Flag-tagged human AGO proteins in RISC immunoprecipitates (Supplementary Fig. 5c ). As predicted from the results of published studies 32 , there was enrichment for all known target mRNAs of miR-21 under miR-21-overexpression conditions, which confirmed the fidelity of our assay ( Supplementary Fig. 5d,e) . Using the same experimental conditions, after confirming the expression of and enrichment for miR-US4-1 (Fig. 2e) and Flagtagged human AGO proteins (Fig. 2f ) in whole-cell lysates and immunoprecipitates, we examined the physical interaction of miR-US4-1 with ERAP1b mRNA by quantitative real-time PCR. We did not detect enrichment for ERAP1a mRNA in the presence of miR-US4-1 (Fig. 2g) . In contrast, there was about 3.8-fold enrichment for ERAP1b mRNA solely when miR-US4-1 was overexpressed (Fig. 2h) . As expected, there was enrichment for neither ERAP1 isoform when miR-US4-1(M) was expressed (Fig. 2g,h ). Together these results demonstrated that miR-US4-1 physically interacted with ERAP1b mRNA in the RISC.
Downregulation of ERAP1 during HCMV infection
We next investigated whether ERAP1 was downregulated by miR-US4-1 during infection with HCMV. Because the pre-miRNA or mature miRNA sequence of miR-US4-1 is located in the 5′ UTR of putative transcripts encoding US5, complete deletion of the entire pre-miRNA sequence from the HCMV genome might affect the expression of neighboring genes near the miR-US4-1 sequence. Thus, to exclude the possibility of any side effects of deletion of the full sequence of miR-US4-1, we generated a mutant of laboratory HCMV strain AD169 (HCMV∆US4) in which processing of the miR-US4-1 primary transcript by the RNase Drosha was defective by substituting only six nucleotides around the predicted cropping site that contains three nucleotides of the 5′-end of the mature miR-US4-1 (Supplementary Fig. 6 ). To confirm the hypothesis that an intact virus was generated without disruption of the entire HCMV genome, we constructed a control revertant virus whose genome sequence was theoretically identical to that of wildtype HCMV AD169 by using HCMV∆US4 as a template, and then infected human foreskin fibroblast (HFF) cells with wild-type HCMV, HCMV∆US4 or revertant HCMV, followed by an RNase-protection assay of miR-US4-1 expression. For infection with wild-type or revertant HCMV, miR-US4-1 expression began at about 24 h after infection and increased until 72 h after infection, whereas miR-US4-1 was not expressed in HFF cells infected with HCMV∆US4 (Fig. 3a) . Immunoblot analysis of lysates of the infected cells showed that the overall amount of ERAP1 protein decreased after infection with wild-type or revertant HCMV, whereas it remained unchanged in cells infected with HCMV∆US4 (Fig. 3b) . The expression of miR-US4-1 did not affect expression of the irrelevant targets IE1-IE2 and GAPDH (Fig. 3b) , which indicated miR-US4-1 had a specific effect on ERAP1 expression.
We next analyzed the alteration in the abundance of ERAP1 mRNA isoforms during the course of infection. We detected no difference between infection with wild-type or revertant HCMV in the amount of ERAP1a mRNA throughout the course of infection ( Supplementary  Fig. 7a ). Whereas infection with HCMV∆US4 had little effect on the amount of ERAP1b mRNA, infection with wild-type HCMV resulted in less ERAP1b mRNA, which reached about 10% of that in uninfected HFF cells at 72 h after infection. Expression of miR-US4-1 did not affect the expression of IE1 mRNA (Supplementary Fig. 7b ), which indicated that miR-US4-1 had a specific effect on the expression of ERAP1b mRNA. These results suggested that the downregulation of ERAP1 protein resulted mainly from miR-US4-1-mediated downregulation of ERAP1b mRNA.
Inhibition of ovalbumin precursor trimming by miR-US4-1
As part of our effort to determine the biological relevance of miR-US4-1, we initially assessed the effect of miR-US4-1 on the production of peptide generated from ovalbumin (OVA) amino acids 257-264 (SIINFEKL; also known as OVA8) from an ovalbumin-derived precursor through the use of the well-known OVA8 experimental system 5, 29 . 
A r t i c l e s
We transfected mouse H-2K b -expressing HeLa cells with vector encoding OVA8 or N5OVA8, an OVA8 peptide with an extension of five amino acids (LEQLESIINFEKL), along with miRNA or siRNA. Because each peptides was fused to the C-terminal end of ubiquitin to allow post-translational cleavage of the peptide from cytosolic ubiquitin by ubiquitin C-terminal hydrolase 34 and ERAP1 can trim the N5OVA8 precursor to mature OVA8 peptide 29 , we monitored the generation of OVA8 by measuring the response of the B3Z86/90.14 (B3Z) mouse T cell hybridoma. As B3Z T cells are from a CD8 + T cell hybridoma line generated by fusion of the OVA-H-2K b -specific cytotoxic clone B3 with a β-galactosidase-inducible derivative of the mouse thymoma BW5147 and engineered to secrete β-galactosidase when its T cell antigen receptor engages an H-2K b -OVA8 complex 35, 36 , the B3Z T cell response can be measured by quantification of β-galactosidase production.
In confirming the specific and sufficient knockdown of ERAP1b mRNA by miR-US4-1 to the amount in siERAP1-treated HeLa cells (Fig. 4a) , we found that miR-US4-1 expression in mouse H-2K b -expressing HeLa cells transfected to express N5OVA8 led to a lower B3Z response than did expression of control miRNA (siGFP) in these cells (Fig. 4b) . We also found that expression of miR-US4-1(M) did not produce a lower the B3Z response, whereas siERAP1 as a control was able to inhibit the B3Z response (Fig. 4b) . In a control experiment, we observed that expression of miR-US4-1, siERAP1 or miR-US4-1(M) in cells expressing OVA8 had no effect on the B3Z responses (Fig. 4c) . In addition, the expression of miR-US4-1 did not affect the steady-state concentration of components of the MHC class I antigen-presentation machinery, such as MHC class I heavy chain, ERp57, protein disulfide isomerase or tapasin ( Supplementary  Fig. 8 ). In accordance with published observations obtained with ERAP1-deficient mice 34, 37, 38 , our findings indicated that miR-US4-1 was able to inhibit trimming of the OVA8 precursor to OVA8 mature peptide by targeting ERAP1.
Subversion of HCMV-specific CTL responses by miR-US4-1
To directly demonstrate the physiological importance of miR-US4-1, we did CTL assays in the presence or absence of miR-US4-1 in the context of HCMV infection using CD8 + HCMV-specific CTL clones from HCMV-seropositive human donors ( Table 1) . Initially, we investigated whether ERAP1 is involved in the generation of HCMV-derived CTL epitopes through the use of an in vitro ERAP1 trimming assay. We incubated each synthetic peptide precursor (with a two-amino acid extension at the N terminus of the mature form) with various amounts of recombinant ERAP1. We monitored the generation of mature epitopes by analytical high-performance liquid chromatography (Fig. 5a) and calculated the rate of mature epitope generation ( Table 1 ). All epitope precursors tested were effectively trimmed to their mature epitopes (UL23 amino acids 34-42 (UL23 (34-42) ), IE1(88-96), UL28(327-335), UL16(162-170) and UL105(715-723)). In the case of UL105(715-723), the rate of generation of mature epitope was slower than that of other epitopes, and it was further trimmed into short peptides by ERAP1 (Fig. 5a) . These in vitro results suggest that ERAP1 may be involved in the generation of a broad spectrum of HCMV epitopes.
The US2-US11 region of wild-type HCMV AD169 encodes several immunoevasion proteins that downregulate the cell surface expression of MHC class I molecules 1 . To overcome the limitations imposed by these immunoevasion proteins and to test the exclusive effect of miR-US4-1 on CTL response, we used HCMV RV798, a version of a mutant laboratory strain of HCMV with deletion of the US2-US11 genome region. Infection with HCMV RV798, unlike infection with wild-type HCMV or HCMV∆US4, slightly upregulated the surface expression of MHC class I molecules (Supplementary Fig. 9 ). We transfected synthetic miR-US4-1 into all autologous dermal fibroblasts (fibroblasts CP, RT and DK, which were derived from HCMV-seropositive patients and correspond to CTL clones in Table 1 ) twice before infection. At 24 h after the second transfection, we infected fibroblast cells For HCMV empitopes, the amino acids included in the epitope are in parentheses; bolding in the precursor epitope indicates the two-amino acid N-terminal extension; the generation rate is presented as the moles of mature peptide generated per mole of enzyme per second; fibroblast donors are identified by initials; +, dependent; -, not dependent.
with HCMV RV798 and confirmed by RT-PCR analysis the expression of viral genes encoding proteins containing epitopes used in the in vitro ERAP1 trimming assay (Supplementary Fig. 10 ). The efficiency of knockdown of ERAP1b by miR-US4-1 was as much as 65-80% in all donor fibroblasts at 48 h after infection ( Supplementary  Fig. 11 ). The miR-US4-1-mediated knockdown of ERAP1 inhibited the lysis of antigen-specific target cells by five CTL clones (1B12-24, 1F8-68, 2A1-3, 1A4-1 and 9G4-107; Fig. 5b ). CTL clone IA8-8, specific to the epitope of UL105(715-723), was efficiently able to lyse the target cells regardless of ERAP1 activity (Fig. 5b) , which indicated that not all HCMV epitopes are generated in an ERAP1-dependent manner. Overall, these data provide direct evidence for a critical role of miR-US4-1 in the immunoevasion of CTL responses by targeting ERAP1, a key component of the antigen-processing machinery. Furthermore, our work supports the proposal of an important in vivo role for ERAP1 in antiviral CTL immune responses in humans.
DISCUSSION
In this study, we have shown that HCMV miR-US4-1 targeted ERAP1b mRNA but not ERAP1a mRNA, which resulted in the overall downregulation of ERAP1 protein. We also found that miR-US4-1 specifically bound to ERAP1b mRNA in the RISC complex, and the 3′ UTR of ERAP1b mRNA was targeted by miR-US4-1 in a manner that destabilized or degraded mRNA and eventually led to less ERAP1b mRNA. We demonstrated that during HCMV infection, the amount of ERAP1b mRNA and overall ERAP1 protein expression were inversely proportional to miR-US4-1 expression. Furthermore, we showed that miR-US4-1 inhibited the lysis of infected target cells by CTLs, which provided evidence of its physiological relevance. Thus, our results have identified a previously unknown miRNA-based immunoevasion strategy in which miR-US4-1 interferes with MHC class I-mediated antigen presentation by targeting ERAP1, a key enzyme involved in catalyzing the production of antigenic peptides in the endoplasmic reticulum. ERAP1 is critical in establishing immune responses to some viral epitopes. ERAP1 deficiency in mice affects the peptide pool during infection with mouse choriomeningitis virus 39 or lymphocytic choriomeningitis virus 37 , as well as CD8 + T cell responses to antigens derived from lymphocytic choriomeningitis virus 38 or influenza virus 37 . In ERAP1-deficient mice, many unstable MHC class I-bound peptides, probably with N-terminal extension, are presented to the cell surface 8 . In our experiments with HCMV-specific CD8 + CTL clones derived from HCMV-seropositive donors, the generation of four epitopes (UL23(34-42), IE1(88-96), UL28(327-335) and UL16(162-170)) among five HCMV epitopes tested was affected by ERAP1. On the basis of published studies of ERAP1-deficient mice and our findings here, we conclude that downregulation of ERAP1 influences the production of many HCMV-derived antigenic peptides during viral infection, which results in evasion of the recognition of viral antigen by CD8 + T cells during the host immune response.
In addition to ERAP1, two other aminopeptidases involved in antigenic peptide processing, ERAP2 (L-RAP) and PLAP (IRAP), are expressed by human cells. ERAP2 can efficiently trim some kinds of epitopes that are distinct from ERAP1-trimmed epitopes 40 , and it can physically bind to ERAP1 (ref. 6 ), which suggests that ERAP1 and ERAP2 might function in concert to produce a variety of MHC class I epitopes in the endoplasmic reticulum. However, not only is ERAP1 expressed more ubiquitously than ERAP2, but its overall expression is higher than that of ERAP2 in human cell lines 6, 41 . In addition, although PLAP can produce distinct antigenic peptides, it is specialized to localize to intracellular vesicles 42 . Therefore, ERAP1 seems to be the main enzyme that trims antigenic peptides in the endoplasmic reticulum of human cells. In this context, 
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it is plausible that HCMV has evolved a strategy to 'preferentially' target ERAP1 rather than other aminopeptidases to inhibit the presentation of epitopes derived from viral gene products under the selective pressure of the host immune response. Of course, it is still possible that the expression or function of ERAP2 and PLAP might also be regulated by HCMV or other viruses for their survival. For a virus to survive, it is crucial that the virus block the presentation of viral antigenic peptides to CD8 + T cells at the immediate-early or early stage of infection. The US2-US11 region of the HCMV genome encodes immunoevasion proteins that can inhibit antigen presentation by MHC class I (ref. 1). The physiological importance of the US2-US11 region has been emphasized by the finding that superinfection of rhesus cytomegalovirus-infected rhesus macaques requires evasion of CD8 + T cell immunity by homologs of the HCMV glycoproteins US2, US3, US6 and US11 (ref. 43) . Given that miR-US4 is expressed together with these immunoevasion proteins at the early stage of infection, miR-US4 probably acts together and simultaneously with these immunoevasion proteins for evasion of the immune response. Unlike the 'US' glycoproteins, viral miRNAs are not immunogenic, and thus viral miRNAs might offer better options for viruses to establish lifelong latent infection. Our work should expand the scope of immunoevasive gene products beyond viral glycoproteins to viral miRNAs. The identification of cooperation between viral miRNA and viral proteins in immunoevasion emphasizes need to incorporate additional determinants in the design of vaccines against HCMV.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
